GlobalData on MSN
Artivion treats first subject in trial of Arcevo LSA stent graft
Participants included in the trial have been diagnosed with either aortic dissection or aneurysm involving the aortic arch.
SNGX READ THE FULL SNGX RESEARCH REPORT Business Update DMC Confirms No Safety Concerns for Ongoing Phase 3 FLASH2 Trial On ...
Verywell Health on MSN
Ask the Expert: A Registered Dietitian Explains How Nutrition Can Support Brain Health
The food you eat can affect how well your brain works and help prevent dementia or Alzheimer's disease later in life. Find ...
A more likely explanation of the results, experts argued, is that insomnia itself — or a health condition that can cause ...
Three new Cochrane reviews find evidence that GLP-1 drugs lead to clinically meaningful weight loss, though industry-funded ...
Introduction Burnout and reduced well-being are highly prevalent among Japanese medical students during clinical training. Scalable, evidence-based interventions are urgently needed. This protocol ...
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced third quarter 2025 financial results ...
Your team knows you're struggling before you do. They're watching your patterns—and your best people may already be planning ...
Will partner USA’s 10X Health and UK’s REVIV Global to deliver hyper-personalised solutions using genetic insights, blood ...
Background Relationships and sex education (RSE) impacts some sexual behaviours but could be strengthened by incorporating ...
Secretary of the Ministry of Ayush, Padma Shri Vaidya Rajesh Kotecha, explains how Ayurveda is being integrated into India’s ...
Mass General Brigham researchers used real-world data to conduct a head-to-head study to investigate cardioprotective effects, finding both medications reduced risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results